Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C25H46N.Br |
| Molecular Weight | 440.543 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Br-].CCCCCCCCCCCCCCCC[N+](C)(C)CC1=CC=CC=C1
InChI
InChIKey=DLNWMWYCSOQYSQ-UHFFFAOYSA-M
InChI=1S/C25H46N.BrH/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23-26(2,3)24-25-21-18-17-19-22-25;/h17-19,21-22H,4-16,20,23-24H2,1-3H3;1H/q+1;/p-1
| Molecular Formula | C25H46N |
| Molecular Weight | 360.6394 |
| Charge | 1 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | BrH |
| Molecular Weight | 80.912 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Cetalkonium chloride is a cationic quaternary ammonium surfactant, which is used for the treatment of mouth ulcers and sores (Bonjela trade name). It is also serves as an excipient for the purpose of long-term stabilization of ciclosporin ocular formulation, used in patients with dry eye syndrom (Ikervis trade name). The antibacterial properties of cetalkonium can be explained by its detergent character. Once applied, cetalkonium blocks the survival of biofilm forming bacterias.
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Curative | BONJELA Approved UseFor the relief of pain, discomfort and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots due to orthodontic devices. To help to fight minor mouth infection and aid healing of sore spots and ulcers due to dentures and orthodontic devices. |
|||
| Inactive ingredient | IKERVIS Approved UseTreatment of severe keratitis in adult patients with dry eye disease, which has not improved despite treatment with tear substitutes. Launch Date2015 |
|||
| Primary | BONJELA Approved UseFor the relief of pain, discomfort and inflammation caused by common mouth ulcers, cold sores, denture and sore spots, as well as mouth ulcers, and sore spots due to orthodontic devices. To help to fight minor mouth infection and aid healing of sore spots and ulcers due to dentures and orthodontic devices. |
Doses
| Dose | Population | Adverse events |
|---|---|---|
0.1 % 1 times / day single, topical Studied dose Dose: 0.1 %, 1 times / day Route: topical Route: single Dose: 0.1 %, 1 times / day Sources: |
healthy, 28 to 55 years n = 8 Health Status: healthy Age Group: 28 to 55 years Sex: M+F Population Size: 8 Sources: |
Other AEs: Contact dermatitis... |
AEs
| AE | Significance | Dose | Population |
|---|---|---|---|
| Contact dermatitis | 37.5% | 0.1 % 1 times / day single, topical Studied dose Dose: 0.1 %, 1 times / day Route: topical Route: single Dose: 0.1 %, 1 times / day Sources: |
healthy, 28 to 55 years n = 8 Health Status: healthy Age Group: 28 to 55 years Sex: M+F Population Size: 8 Sources: |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Detection of cationic surfactants in oral rinses and a disinfectant formulation using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. | 2001 |
|
| Exciplex-type behavior and partition of 3-substituted indole derivatives in reverse micelles made with benzylhexadecyldimethylammonium chloride, water and benzene. | 2001 Feb |
|
| Occupational allergic contact dermatitis from alkylammonium amidobenzoate. | 2001 May-Jun |
|
| Effect of the deaeration on the adsorption of some cationic surfactants at the mercury/electrolyte solution interface. | 2006 Apr 15 |
|
| Condensed film formation of binary mixtures of cetyltrimethylammonium bromide and cetyldimethylbenzylammonium chloride in a wide potential region at the mercury/electrolyte interface. | 2006 Dec 1 |
|
| A new multiphasic buffer system for benzyldimethyl-n-hexadecylammonium chloride polyacrylamide gel electrophoresis of proteins providing efficient stacking. | 2006 Feb |
|
| Dechlorination of beta-methylallyl chloride by electrogenerated [Co(I)(bipyridine)3]+: an electrochemical study in the presence of cationic surfactants. | 2006 May 15 |
|
| Effect of deaeration on the adsorption of a mixture of cetyltrimethylammonium bromide and cetyldimethylbenzylammonium chloride at the mercury/electrolyte solution interface. | 2007 Jun 15 |
|
| Comparative study of the photophysical behavior of fisetin in homogeneous media and in anionic and cationic reverse micelles media. | 2007 May-Jun |
|
| Reduction of quaternary ammonium-induced ocular surface toxicity by emulsions: an in vivo study in rabbits. | 2008 Jan 31 |
|
| Characterization of multifunctional reverse micelles' interfaces using hemicyanines as molecular probes. II: Effect of the surfactant. | 2009 May 14 |
|
| On the formation of new reverse micelles: a comparative study of benzene/surfactants/ionic liquids systems using UV-visible absorption spectroscopy and dynamic light scattering. | 2009 Sep 15 |
|
| Highlights on the capacities of "Gel-based" proteomics. | 2010 Apr 28 |
|
| [Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy]. | 2010 Jun |
|
| Synthesis, self-aggregation and biological properties of alkylphosphocholine and alkylphosphohomocholine derivatives of cetyltrimethylammonium bromide, cetylpyridinium bromide, benzalkonium bromide (C16) and benzethonium chloride. | 2013 Aug |
Patents
Sample Use Guides
Massage one centimetre of the topical formulation (Bonjela) onto the affected area (mouth ulcers and sores) and leave at least 30 min in case of denture sores. In dry eye disease, the recommended dose is one drop of the ocular formulation (Ikervis) once daily to be applied to the affected eye(s) at bedtime.
Route of Administration:
Other
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 04:48:51 GMT 2023
by
admin
on
Sat Dec 16 04:48:51 GMT 2023
|
| Record UNII |
UHU0390Z3J
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
UHU0390Z3J
Created by
admin on Sat Dec 16 04:48:51 GMT 2023 , Edited by admin on Sat Dec 16 04:48:51 GMT 2023
|
PRIMARY | |||
|
DBSALT001775
Created by
admin on Sat Dec 16 04:48:51 GMT 2023 , Edited by admin on Sat Dec 16 04:48:51 GMT 2023
|
PRIMARY | |||
|
222-556-5
Created by
admin on Sat Dec 16 04:48:51 GMT 2023 , Edited by admin on Sat Dec 16 04:48:51 GMT 2023
|
PRIMARY | |||
|
DTXSID90956729
Created by
admin on Sat Dec 16 04:48:51 GMT 2023 , Edited by admin on Sat Dec 16 04:48:51 GMT 2023
|
PRIMARY | |||
|
263517
Created by
admin on Sat Dec 16 04:48:51 GMT 2023 , Edited by admin on Sat Dec 16 04:48:51 GMT 2023
|
PRIMARY | |||
|
165133
Created by
admin on Sat Dec 16 04:48:51 GMT 2023 , Edited by admin on Sat Dec 16 04:48:51 GMT 2023
|
PRIMARY | |||
|
3529-04-2
Created by
admin on Sat Dec 16 04:48:51 GMT 2023 , Edited by admin on Sat Dec 16 04:48:51 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
